Expert Rev Clin Pharmacol. 2013;6(3):271-288. Triptans are highly effective for short-term treatment of acute migraine attacks. They are effective in MA or MO, but are not intended for use in ...

5-hydroxytriptamine is a key mediator in the pathogenesis of migraine and thus 5-HT 1-receptor agonists are the principal drugs for acute migraine therapy. There are three classes of drugs for ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks ...

This slow ramp-up period often leads to treatment abandonment. “With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks or ...

Over-the-counter medications can often treat migraine symptoms. However, if your migraine symptoms persist, you may want to talk with a doctor about prescription options. Migraine is a health ...

Several types of migraine medications are available in nasal spray ... You can learn more about how we ensure our content is accurate and current by reading our editorial policy.

Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment, according to a recent study published in Neurology. "With many current drugs to prevent migraine, it ...

The agency then approved the device for use in the treatment of migraine attacks in 2017 ... headset that delivers pulses of electrical current to stimulate the occipital and trigeminal nerves.

If you have mild and less frequent migraine attacks, try other pain relievers first, including acetaminophen (Tylenol and generics); nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin ...

Now, John et al. have demonstrated the benefits of yoga therapy in the treatment of migraine. The researchers enrolled 72 patients who had migraine without aura. Following a 4-week run-in period ...

But the body that approves new drugs said there were doubts whether it was good enough or worth the money. Charities said it seemed to be a "very bad day" for migraine suffers. Current drugs to ...